These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 39079155)

  • 1. Novel therapeutic receptor agonists and antagonists in allergic conjunctivitis.
    Abu SL; Hehar NK; Chigbu DI
    Curr Opin Allergy Clin Immunol; 2024 Oct; 24(5):380-389. PubMed ID: 39079155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-inflammatory effects of therapies for ocular allergy.
    Mantelli F; Calder VL; Bonini S
    J Ocul Pharmacol Ther; 2013 Nov; 29(9):786-93. PubMed ID: 24044620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis.
    Castillo M; Scott NW; Mustafa MZ; Mustafa MS; Azuara-Blanco A
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD009566. PubMed ID: 26028608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis.
    Bielory L; Lien KW; Bigelsen S
    Drugs; 2005; 65(2):215-28. PubMed ID: 15631542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergic conjunctivitis: a comprehensive review of the literature.
    La Rosa M; Lionetti E; Reibaldi M; Russo A; Longo A; Leonardi S; Tomarchio S; Avitabile T; Reibaldi A
    Ital J Pediatr; 2013 Mar; 39():18. PubMed ID: 23497516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seasonal and perennial allergic conjunctivitis.
    Wong AH; Barg SS; Leung AK
    Recent Pat Inflamm Allergy Drug Discov; 2014; 8(2):139-53. PubMed ID: 25000933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in pharmacotherapy for allergic conjunctivitis.
    Abelson MB; Shetty S; Korchak M; Butrus SI; Smith LM
    Expert Opin Pharmacother; 2015 Jun; 16(8):1219-31. PubMed ID: 25943976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostics and new developments in the treatment of ocular allergies.
    Kari O; Saari KM
    Curr Allergy Asthma Rep; 2012 Jun; 12(3):232-9. PubMed ID: 22382607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A current appreciation of sites for pharmacological intervention in allergic conjunctivitis: effects of new topical ocular drugs.
    Yanni JM; Sharif NA; Gamache DA; Miller ST; Weimer LK; Spellman JM
    Acta Ophthalmol Scand Suppl; 1999; (228):33-7. PubMed ID: 10337430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Seasonal and perennial allergic rhinoconjunctivitis].
    Schröder K; Finis D; Meller S; Buhren BA; Wagenmann M; Geerling G
    Klin Monbl Augenheilkd; 2014 May; 231(5):496-504. PubMed ID: 24799168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist.
    Baiula M; Spartà A; Bedini A; Carbonari G; Bucolo C; Ward KW; Zhang JZ; Govoni P; Spampinato S
    Mol Vis; 2011; 17():3208-23. PubMed ID: 22194647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II drugs under investigation for allergic conjunctivitis.
    Baiula M; Spampinato S
    Expert Opin Investig Drugs; 2014 Dec; 23(12):1671-86. PubMed ID: 25062902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulators for conjunctivitis.
    Pacharn P; Vichyanond P
    Curr Opin Allergy Clin Immunol; 2013 Oct; 13(5):550-7. PubMed ID: 23974685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent patents and emerging therapeutics in the treatment of allergic conjunctivitis.
    Mishra GP; Tamboli V; Jwala J; Mitra AK
    Recent Pat Inflamm Allergy Drug Discov; 2011 Jan; 5(1):26-36. PubMed ID: 21171952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DP2 (CRTh2) antagonism reduces ocular inflammation induced by allergen challenge and respiratory syncytial virus.
    Stebbins KJ; Broadhead AR; Musiyenko A; Barik S; Scott JM; Truong YP; Stearns BA; Hutchinson JH; Prasit P; Evans JF; Lorrain DS
    Int Arch Allergy Immunol; 2012; 157(3):259-68. PubMed ID: 22042170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergic conjunctivitis and H1 antihistamines.
    del Cuvillo A; Sastre J; Montoro J; Jáuregui I; Dávila I; Ferrer M; Bartra J; Mullol J; Valero A
    J Investig Allergol Clin Immunol; 2009; 19 Suppl 1():11-8. PubMed ID: 19476049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of allergic conjunctivitis.
    Bartlett JD
    Ophthalmology; 1997 Mar; 104(3):345-6. PubMed ID: 9082254
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic options in ocular allergic disease.
    Hingorani M; Lightman S
    Drugs; 1995 Aug; 50(2):208-21. PubMed ID: 8521755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging drugs for allergic conjunctivitis.
    Ridolo E; Montagni M; Caminati M; Senna G; Incorvaia C; Canonica GW
    Expert Opin Emerg Drugs; 2014 Jun; 19(2):291-302. PubMed ID: 24661261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of histamine H(4) receptor in allergic conjunctivitis in mice.
    Nakano Y; Takahashi Y; Ono R; Kurata Y; Kagawa Y; Kamei C
    Eur J Pharmacol; 2009 Apr; 608(1-3):71-5. PubMed ID: 19249296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.